Stories
Slash Boxes
Comments

SoylentNews is people

posted by martyb on Tuesday September 01 2020, @03:10AM   Printer-friendly
from the knit-wit dept.

Arthur T Knackerbracket has found the following story:

"One of the major challenges to healing after [a] nerve injury is the formation of a glial scar."

A glial scar is formed by cells and biochemicals that knit together tightly around the damaged nerve. In the short term, this protective environment shields the nerve cells from further injury, but in the long term it can inhibit nerve repair.

About two decades ago, scientists discovered that a natural enzyme known as chondroitinase ABC — produced by a bacterium called Proteus vulgaris — can selectively degrade some of the biomolecules that make up the glial scar.

By changing the environment around the damaged nerve, chondroitinase ABC has been shown to promote regrowth of nerve cells. In animal models, it can even lead to regaining some lost function.

But progress has been limited by the fact that chondroitinase ABC is not very stable in the places where researchers want to use it.

"It's stable enough for the environment that the bacteria live in, but inside the body it is very fragile," says [senior author and University of Toronto Engineering professor Molly] Shoichet. "It aggregates, or clumps together, which causes it to lose activity. This happens faster at body temperature than at room temperature. It is also difficult to deliver chondroitinase ABC because it is susceptible to chemical degradation and shear forces typically used in formulations."

[...] "The wild type chondroitinase ABC loses most of its activity within 24 hours, whereas our re-engineered enzyme is active for seven days," says Marian Hettiaratchi, the other co-lead author of the paper. A former postdoctoral fellow in Shoichet's lab, Hettiaratchi is now a professor of bioengineering at the University of Oregon's Phil and Penny Knight Campus for Accelerating Scientific Impact.

"This is a huge difference. Our improved enzyme is expected to even more effectively degrade the glial scar than the version commonly used by other research groups," says Hettiaratchi.

Journal Reference:
Marian H. Hettiaratchi, Matthew J. O'Meara, Teresa R. O'Meara, et al. Reengineering biocatalysts: Computational redesign of chondroitinase ABC improves efficacy and stability [open], Science Advances (DOI: 10.1126/sciadv.abc6378)

-- submitted from IRC


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 3, Touché) by sjames on Tuesday September 01 2020, @04:33AM

    by sjames (2882) on Tuesday September 01 2020, @04:33AM (#1044828) Journal

    Since SN was quoting, yes.

    Starting Score:    1  point
    Moderation   +1  
       Touché=1, Total=1
    Extra 'Touché' Modifier   0  
    Karma-Bonus Modifier   +1  

    Total Score:   3